Tokyo - Delayed Quote JPY

Nano Holdings, Inc. (4571.T)

77.00 -2.00 (-2.53%)

At close: 3:30:00 PM GMT+9

Chart Range Bar

Loading chart for 4571.T

Previous Close 79.00
Open 78.00
Bid 77.00 x --
Ask 78.00 x --
Day's Range 76.00 - 79.00
52 Week Range 72.00 - 195.00
Volume 319,500
Avg. Volume 651,675
Market Cap (intraday) 6.442B
Beta (5Y Monthly) 0.42
PE Ratio (TTM) --
EPS (TTM) -13.44
Earnings Date (est.) --
Forward Dividend & Yield -- (0.00%)
Ex-Dividend Date --
1y Target Est --

Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company's pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings, Inc. in December 2025. Nano Holdings, Inc. was incorporated in 1996 and is headquartered in Minato, Japan.

www.nanomrna.co.jp

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

4571.T

45.77%

Nikkei 225 (^N225)

25.31%

1-Year Return

4571.T

51.88%

Nikkei 225 (^N225)

20.36%

3-Year Return

4571.T

58.15%

Nikkei 225 (^N225)

97.44%

5-Year Return

4571.T

75.40%

Nikkei 225 (^N225)

113.69%

Earnings Per Share (GAAP)

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q1 FY27

Revenue 35M

Earnings -281M

Profit Margin -802.86%

FY25

FY26

FY27

-200M

-100M

-2500.0%

-2000.0%

-1500.0%

-1000.0%

-500.0%

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-14.34%
Return on Equity (ttm)

-34.32%
Revenue (ttm)

202M
Net Income Avi to Common (ttm)

-1.02B
Diluted EPS (ttm)

-13.44

Balance Sheet and Cash Flow

Total Cash (mrq)

4.22B
Total Debt/Equity (mrq)

36.21%
Levered Free Cash Flow (ttm)

--

4564.T

4563.T

4592.T

4978.T

4565.T

U.S. markets close in 2h 43m

Nano Holdings, Inc. (4571.T)

0.00%

-18.95%

-44.60%

-45.77%

-51.88%

-75.40%

-72.00%

Nano Holdings, Inc. Overview Biotechnology / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share (GAAP)

Revenue vs. Earnings

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch